United States Biotechnology & Medical Research

Fibrobiologics Inc (FBLG)

Track

Recent insider activity at Fibrobiologics Inc. shows a series of buy transactions by key executives, including the Chief Executive Officer, Chief Financial Officer, Chief Scientific Officer, and General Counsel. The most recent trading occurred on March 4, 2026, with multiple executives making purchases.
Stock chart
Ticker: FBLG Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Khoja Hamid
Chief Scientific Officer
1 purchase — total 11,400 USD
Buy 4 Mar 2026
Value US$4,231,245.24 | Price 41.84 | Shares 44,847
Buy 4 Mar 2026
Value US$2,535,787.49 | Price 146.58 | Shares 9,416
Buy 3 Mar 2026
Value US$7,372.82 | Price 0.41 | Shares 18,200
Buy 2 Mar 2026
Value US$6,152.08 | Price 0.35 | Shares 17,428
Buy 2 Mar 2026
Value US$28,973.00 | Price 0.41 | Shares 70,000
Buy 27 Feb 2026
Value US$13,056.00 | Price 0.33 | Shares 40,000
Buy 11 Dec 2025
Value US$47,600.00 | Price 0.34 | Shares 140,000
Buy 27 May 2025
Value US$16,800.00 | Price 0.84 | Shares 20,000
Buy 12 Aug 2024
Value US$19,000.00 | Price 1.90 | Shares 10,000
Buy 12 Aug 2024
Value US$16,269.00 | Price 1.91 | Shares 8,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-04 B Purchase
2.8
Khoja Hamid

Chief Scientific Officer

Officer
44,847 -42.9%
41.84
US$4,231,245 		44,847 -42.9% 41.84 US$4,231,245
2026-03-04 2026-03-04 B Purchase
3.7
O'HEERON PETE

CHIEF EXECUTIVE OFFICER

Executive Director
9,416 -13.0%
146.58
US$2,535,787 		9,416 -13.0% 146.58 US$2,535,787
2026-03-04 2026-03-03 B Purchase
3.7
O'HEERON PETE

CHIEF EXECUTIVE OFFICER

Executive Director
32,314 +18.5%
163.41
US$937,577 		32,314 +18.5% 163.41 US$937,577
2026-03-04 2026-03-02 B Purchase
3.7
O'HEERON PETE

CHIEF EXECUTIVE OFFICER

Executive Director
17,428 +0.3%
0.35
US$6,152 		17,428 +0.3% 0.35 US$6,152
2026-03-03 2026-03-02 B Purchase
Davis Jason

Chief Financial Officer

Officer
70,000 +inf%
0.41
US$28,973 		70,000 +inf% 0.41 US$28,973
2026-03-02 2026-02-27 B Purchase
1.5
GARCIA RUBEN A

General Counsel

Officer
40,000 +28.6%
0.33
US$13,056 		40,000 +28.6% 0.33 US$13,056
2025-12-12 2025-12-11 B Purchase
1.5
GARCIA RUBEN A

General Counsel

Officer
140,000 +inf%
0.34
US$47,600 		140,000 +inf% 0.34 US$47,600
2025-05-27 2025-05-27 B Purchase
2.8
Khoja Hamid

Chief Scientific Officer

Officer
20,000 +177.8%
0.84
US$16,800 		20,000 +177.8% 0.84 US$16,800
2024-08-12 2024-08-12 B Purchase
2.8
Khoja Hamid

Chief Scientific Officer

Officer
10,000 +800.0%
1.90
US$19,000 		10,000 +800.0% 1.90 US$19,000
2024-08-12 2024-08-12 B Purchase
3.7
O'HEERON PETE

Chief Executive Officer

Executive Director
8,500 +0.1%
1.91
US$16,269 		8,500 +0.1% 1.91 US$16,269
Explore more

More insider trading research around Fibrobiologics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America